New research shows GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

Plastic surgeons are reporting a surge in patients demanding 'dangerous' cosmetic operations due to the effects of losing a ...